Joshua Brody

Joshua Brody, MD

  • ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
  • ASSOCIATE PROFESSOR | Oncological Sciences


Hematology-Oncology, Cancer (Oncology)

Joshua Brody, MD, is the Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai and a faculty member of the Icahn Genomics Institute. Since joining Mount Sinai in 2011, he has developed a robust clinical program, as well as a translational Cancer Immunotherapy Lab which investigates basic and applied tumor immunology for the development of novel therapies, particularly for lymphomas, breast cancer, and head/neck cancer with results published in top-tier journals including Nature Medicine and Cancer Discovery.  Dr. Brody has pioneered a therapeutic vaccine approach—in situ vaccination—that induces anti-tumor immunity at the tumor site and can also cause regression of tumors throughout the body. He has also developed a way to use increase the power of immunotherapy drugs against treatment-resistant lymphomas by combining them with stem cell transplantation.  Recently, his group discovered a novel approach to improve immunotherapies by preventing a common escape mechanism that tumors use to evade CAR-T and bispecific antibody therapies.

Dr. Brody’s research receives funding from numerous grantors, including the National Institutes of Health, the Cancer Research Institute, the Damon Runyon Cancer Research Foundation, and the Lymphoma Research Foundation. He is a member of many professional organizations, including the Society for the Immunotherapy of Cancer and the Alliance for Clinical Trials in Oncology.

Dr. Brody is committed to partnering with his patients to choose the most appropriate treatment approach that offers the best outcomes with excellent quality of life.

Learn more about Dr. Brody's research at The Brody Lab.

Dr. Brody is on Twitter at @joshuabrodyMD


Medical Oncology

American Board of Internal Medicine

Clinical Focus

  • Adult Non-Hodgkin's Lymphoma
  • Hodgkin's Disease
  • Hodgkin's Lymphoma
  • Leukemia
  • Lymphoma
  • Mantle Cell Lymphoma
  • Primary Central Nervous System Lymphoma

Multi-Disciplinary Training Areas

Cancer Biology [CAB], Immunology [IMM]


BA, Harvard University

MD, SUNY StonyBrook Medical Center

MD, State University of New York Stony Brook School of Medicine

Residency, Internal Medicine, Yale University Health Services

Fellowship, Medical Oncology, Stanford University School of Medicine

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.